Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
GLN-1062 Memogain Alzheimer's Disease (Phase 1) Galantos Pharma, Neurodyn Cholinergic System Small Molecule
HTL0018318 Alzheimer's Disease (Phase 1), Dementia with Lewy Bodies (Phase 2) Allergan plc, Sosei Heptares Cholinergic System Small Molecule
SUVN-G3031 Alzheimer's Disease (Phase 1) Suven Life Sciences Ltd Cholinergic System, Other Neurotransmitters Small Molecule